 ABINGDON, OXFORDSHIRE ACCESSWIRE May 21, 2020 Midatech Pharma PLC MTPH.LMTP, an RD; biotechnology company focused on delivering innovative oncology and rare disease products to patients, today announced the closing of its previously announced registered direct offering the Offering of 1,818,182 of its American Depositary Shares ADSs each ADS representing five of the Companys ordinary shares the New Ordinary Shares at a purchase price of US1.65 per ADS equivalent to 0.27 per New Ordinary Share. Additionally, in a concurrent private placement, the Company issued to the investors unregistered warrants to purchase up to 1,818,182 ADSs Warrant ADSs. The net proceeds to Midatech from the offering are expected to be approximately US2.6 million 2.1 million, after deducting the placement agents fees and other estimated offering expenses. 